Innova launches 'conjugation compatible' antibody purification system
Innova Biosciences says its AbPure Protein A-based system removes the need to undergo an additional step when purifying antibody in preparation for conjugation
Archives for September 20, 2016
Momenta taps BioFactura's NS0 cell line tech for biosimilar candidate
Momenta Pharmaceuticals has partnered on the development of an undisclosed biosimilar using BioFactura’s StableFast biomanufacturing platform.
Cell and gene therapy investment to continue to grow post-Brexit, CGT Catapult
Brexit will not stifle interest in the UK’s cell and gene therapy space, says the CGT Catapult which has reported a tenfold growth in investment since 2012 to £400m ($520m).